Morning eating and exercise may shield older women from muscle loss

NCT ID NCT07075133

First seen Jun 01, 2026

Summary

This study tests whether eating all meals within an 8-hour window (between early morning and early afternoon) combined with morning exercise can prevent sarcopenia—age-related muscle loss—in postmenopausal women with obesity and type 2 diabetes. Forty-five women will follow either a standard diabetes diet or the early time-restricted eating plan plus morning workouts for 12 weeks. The goal is to see if this timing-based approach improves muscle strength and blood sugar control better than diet alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rangueil Hospital

    Toulouse, France, 31000, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

early time-restricted eating (eTRE) and morning physical activity

What this could lead to

If it works, this could point toward a simple lifestyle strategy to prevent muscle weakness in older women with diabetes and obesity.

What could go wrong

This is a small, early-stage trial with only 45 participants, so results may not apply widely. The intervention is demanding and may be hard to stick with long-term.

Conditions

The condition(s) this trial relates to.

Diabetes Mellitus, Type 2 Obesity Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.